期刊文献+

重组人甲状旁腺激素(1-84)对去卵巢大鼠骨质疏松模型的影响 被引量:5

下载PDF
导出
摘要 目的观察重组人甲状旁腺激素(1-84)对卵巢摘除骨质疏松大鼠的治疗作用。方法 36只4月龄的SD健康雌性大鼠,26只行双侧卵巢摘除术,10只作为假手术组,6 w后各处死6只检测造模效果。余20只骨质疏松模型鼠随机分为PTH组和安慰剂组。PTH组肌肉注射rhPTH(1-84)40μg/kg,每周3次。安慰剂组肌肉注射等量生理盐水,每周3次。治疗8 w后,测定并比较子宫湿重、股骨骨密度(BMD)、血清碱性磷酸酶(ALP)及吡啶酚(PYD)/Cr水平。结果双侧卵巢摘除6 w后,大鼠股骨BMD明显低于假手术组。8 w治疗后,PTH治疗组大鼠股骨BMD明显高于安慰剂组,血ALP及PYD/Cr也高于安慰剂组。结论 rhPTH(1-84)可显著增加BMD,对卵巢摘除诱导的大鼠骨质疏松有效。
出处 《中国老年学杂志》 CAS CSCD 北大核心 2012年第6期1185-1187,共3页 Chinese Journal of Gerontology
基金 云南省社会发展科技计划项目(2007CAO26)
  • 相关文献

参考文献10

  • 1Cosman F,Nieves J,Woelfert L,et al.Parathyroid hormone added to es-tablished hormone therapy:effects on vertebral fracture and maintenance of bone mass after parathyroid hormone withdrawal(J).J Bone Miner Res,2001;16(5):925-31.
  • 2Neer RM,Arnaud CD,Zanchetta JR,et al.Effect of parathyroid hormone(1-34)on fractures and bone mineral density in postmenopausal women with osteoporosis(J).N Engl J Med,2001;344(19):1434-41.
  • 3Reddy Nagareddy P,Lakshmana M.Assessment of experimental osteopo-rosis using CT-scanning,quantitative X-ray analysis and impact test in calcium deficient ovariectomized rats(J).J Pharmacol Toxicol Methods,2005;52(3):350-5.
  • 4Kim MS,Lee YS.Effects of soy isoflavone and/or estrogen treatments on bone metabolism in ovariectomized rats(J).J Med Food,2005;8(4):439-45.
  • 5Yang J,Pham SM,Crabbe DL,et al.Effects of oestrogen deficiency on rat mandibular and tibial microarchitecture(J).Dentomaxillofac Radiol,2003;32(4):247-51.
  • 6刘石平,廖二元,伍汉文,伍贤平,邓小戈.绝经后骨质疏松大鼠模型的综合评价[J].湖南医科大学学报,2001,26(2):111-114. 被引量:26
  • 7王宝利,贾红蔚,权金星,邱明才,张镜宇.尼尔雌醇对去卵巢大鼠胫骨骨重建的影响[J].中华病理学杂志,2004,33(3):255-259. 被引量:5
  • 8王洪复,金慰芳,高建军,顾淑珠,周轶,孙爱龙,胡菲,沈洁,张顺昌.重组人甲状旁腺激素_(1-34)对去卵巢大鼠骨质疏松的治疗作用[J].中国医学科学院学报,2003,25(3):275-279. 被引量:25
  • 9于志锋,金慰芳,顾淑珠,高建军,周轶,王洪复.rhPTH_((1-34))治疗OVX大鼠骨质疏松延后效应的初步研究[J].中国骨质疏松杂志,2005,11(3):278-280. 被引量:3
  • 10Dempster DW.The impact of bone turnover and bone-active agents on bone quality:focus on the hip(J).Osteoporos Int,2002;13(3):349-52.

二级参考文献25

  • 1Silverberg SJ, Shane E, de la Cruz L, et al. Skeletal disease in Primary hyperparathyroidism. J Bone Miner Res,1989, 4:281-291.
  • 2Rubin Mr, Cosman F, Lindsay IL et al. The anabolic effects of parathyroid hormone. Osteoporos Int, 2002, 13:267-277.
  • 3Ejersed C, Andeassen TF, Hauge EM, et al. Parathyroid bormone(1-34) increases vertebral bone mass, compressive strength, and quality in old rats. Bone, 1995, 17(6):507-511.
  • 4Sato M, Vahle J, Schmidt A, et al. Abnormal bone architecture and biomechanical properties with near-lifetime treatment of rats with PTH. Endocrinology, 2002, 143:3230-3242.
  • 5Okimoto N, Tsurukami H, Okazaki Y, et al. Effects of a weekly injection of human parathyroid hormone(1-34) and withdrawal on bone mass, stxength, and tumover in mature ovariectomized rats. Bone, 1998, 22:523-531.
  • 6Brommage R, Hotchkiss CE, Lces CJ, et al. Daily treatment with human recombinant parathyroid hormone(1-34) LY333334,for l year increases bone mass in ovariectomized monkeys.J Clin Endocrinol Metab, 1999. 84(10):3757-3763.
  • 7Sato M, Weatmore M, Clendenon J, et al. Three-dimensional modeling of the effects of parathyroid hormone on bone distribution in lumber vertebrate of ovariectomized cynomolgus macaques. Osteoporm lnt, 2000, 11(10):871-880.
  • 8Ma YL, Cain RI, Helladay DL, et al. Catabolic effects of continuous human PTH (1-38) in vivo is associated with sustained stimulation of RANKL and inhibition of osteoprotegerin and gene-associated bone formation. Endocrinology,2001, 142:4047-4054.
  • 9Locklin RM, Khosla S, Riggs BL. Mechanism of biphasic and catabolic effects of parathyroid hormone(PTH) on bone cells. Bone, 2001, 28 (Suppl):580.
  • 10Jilka RL, Weinstein RS, Bellido T, et al. Increased bone formation by prevention of osteoblast apoptosis with parathyroid hormone. J Clin Invest, 1999, 104:439-446.

共引文献52

同被引文献93

引证文献5

二级引证文献9

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部